Evofem Biosciences/ US30048L2034 /
| 6/24/2022 9:59:31 PM | Chg. +0.05 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 0.37USD | +16.57% | 92,665 Turnover: 38,505.07 |
-Bid Size: - | -Ask Size: - | 0.48 | 0.33 |
GlobeNewswire
3/28
Saundra Pelletier, CEO of Evofem Biosciences, to Receive Honorary Degree from Husson University
GlobeNewswire
3/19/2020
TRACON Pharmaceuticals Announces Appointment of Saundra Pelletier to Board of Directors
GlobeNewswire
4/16/2019
STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Evofem Biosciences, Inc. – EVFM
GlobeNewswire
6/6/2018
Daré Bioscience, Inc. Expands Leadership Team, Appointing David Friend, Ph.D. to Chief Scientific Of...
GlobeNewswire
6/4/2018
Daré Bioscience, Inc. Expands Leadership Team, Appointing Mary Jarosz, RPh, to Global Head of Regula...
GlobeNewswire
1/5/2018
Neothetics Announces Adjournment of Special Stockholders Meeting to Solicit Additional Votes for Mer...
GlobeNewswire
11/8/2017
Neothetics Provides Business Update and Reports Third Quarter 2017 Financial Results